Bruker Corp. Aktie
Bruker Corp. Aktie
Was spricht für und gegen Bruker Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Bruker Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 1,00 % | 3,91 % | -6,40 % | -15,95 % | -21,84 % | - | - |
| Healthequity Inc. | 1,40 % | 0,69 % | 9,85 % | -10,49 % | -7,05 % | 34,26 % | 24,31 % |
| Omnicell Inc. | 0,68 % | -3,29 % | -16,00 % | -9,26 % | -24,23 % | -45,05 % | -73,75 % |
| Myriad Genetics | 3,55 % | 4,08 % | -4,23 % | -49,63 % | -23,02 % | -80,91 % | -84,73 % |
Kommentare
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a




